Lucas Actis Goretta,Amaury Patin,Stephanie Michlig Gonzalez,Susana Camacho,Coline Legrand,Johannes Le Coutre,Euridice Castaneda Gutierrez,Irma Silva Zolezzi
申请号：
US16061527
公开号：
US20200261485A1
申请日:
2016.12.15
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Compositions can comprise the flavanol metabolite 3′；-O-glucuronide epicatechin (3GEC). In some embodiments, the amount of 3GEC is effective to increase energy expenditure, sympathetic nervous system activity, and/or fat oxidation. Such a composition can be used in a method to support weight management or promote weight loss, a method for preventing obesity or overweight, and a method for treating obesity or overweight. In some embodiments, the composition can improve insulin sensitivity, glucose tolerance, cognitive performance, cognition, mood and/or memory. In some embodiments, the composition can achieve a therapeutic effect selected from the group consisting of blood vessel dilation, reduced blood pressure, increased delivery of blood flow to tissues in the body, improvement of blood circulation, e.g. in brain, stimulation of protein synthesis, increased release of growth factors, enhanced immune function, and combinations thereof. In some embodiments, the composition can treat or prevent dysphagia, e.g., by provoking the swallowing reflex.
